CM
CRMD icon

Caption Management’s CorMedix CRMD Stock Holding History

Caption Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-228,600
Closed -$1.55M – 1734
2026
Q1 		$1.55M Buy
+228,600
New +$1.69M 0.01% 890

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Caption Management's CRMD Position: Q2 2026 in Review

Caption Management opened a new position in CorMedix (CRMD) in Q2 2026: 6,380 shares worth $50.1K. The stake represents ﹤0.01% of the portfolio and ranks #1550 among its holdings. This is a return to the name: Caption Management previously reported a position in CRMD as recently as Q1 2025.

Caption Management first reported a position in CRMD in Q1 2025 and has held it in 2 quarters since. The position peaked at $113K in Q1 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Caption Management held 6,380 shares of CorMedix worth $50.1K as of Q2 2026.
  • CorMedix was a new Caption Management position in Q2 2026.
  • CorMedix made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1550 holding.
  • Caption Management first reported a position in CorMedix in Q1 2025 and has held it in 2 quarters since.
  • Caption Management's CorMedix position peaked at $113K in Q1 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.